Neutrophil interactions with sialyl Lewis X on human nonsmall cell lung carcinoma cells regulate invasive behavior.
Neutrophil interactions with sialyl Lewis X on human nonsmall cell lung carcinoma cells regulate invasive behavior.
复制标题
DOI:
10.1002/cncr.26059
复制
发表时间:
2011-10-01
期刊:
影响因子:
6.2
通讯作者:
Farooqui M
中科院分区:
文献类型:
--
作者:
St Hill CA;Krieser K;Farooqui M
The carbohydrate Sialyl Lewis X (sLeX) is expressed on leukocytes and carcinoma cells and binds to selectins during inflammatory processes and early metastasis. Synthesis of sLeX is dependent on activity of enzymes including α(1,3/1,4) fucosyltransferase (FucT-III). Tumor necrosis factor alpha (TNF-α) up-regulates FucT-III resulting in increased sLeX in the airways of patients with respiratory disease, however, the mechanisms that regulate sLeX in the inflammatory tumor microenvironment are not well understood. We stably transfected human lung carcinoma cell lines with the FucT-III gene and exposed them to TNF-α to investigate its role in regulation of sLeX expression and selectin binding ability by semi-quantitative real-time polymerase chain reaction and flow cytometry. We examined cytokine expression of transfected cells using chemiluminescent arrays and ELISA, invasion using Matrigel assays, and alterations in morphology. Human lung tissue arrays were analyzed for immunohistochemical detection of sLeX and neutrophils. Stimulation of FucT-III transfected cells with recombinant human (rh) TNF-α upregulated sLeX expression and increased E-selectin binding. Transfected cells secreted high levels of IL-8, GRO-α and MCP-1. Cells exposed to rhTNF-α, neutrophil conditioned media, and 5:1 ratio cultures of neutrophils to cancer cells significantly increased sLeX expression and invasiveness, and underwent non-adherent morphological changes. In lung carcinomas but not in normal lung tissues, 71% of tumors were highly positive for sLeX expression in areas of increased neutrophil infiltration. Neutrophils may be recruited to areas of FucT-III activity and sLeX expression in lung carcinomas to enhance the invasive and metastatic potential of lung cancer cells.